Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J.

Alzheimers Dement. 2013 Mar;9(2):176-88. doi: 10.1016/j.jalz.2012.03.002. Epub 2012 Oct 5. Review.

2.

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian ZS, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, Laferla F, Perrin S, Whitaker S, Honig L, Mesulam MM, Boeve B, Grossman M, Miller BL, Cummings JL.

Alzheimers Dement. 2013 Mar;9(2):189-98. doi: 10.1016/j.jalz.2012.03.003. Epub 2012 Oct 10. Review.

3.

Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.

Behrouzi R, Liu X, Wu D, Robinson AC, Tanaguchi-Watanabe S, Rollinson S, Shi J, Tian J, Hamdalla HH, Ealing J, Richardson A, Jones M, Pickering-Brown S, Davidson YS, Strong MJ, Hasegawa M, Snowden JS, Mann DM.

Acta Neuropathol Commun. 2016 Mar 31;4:33. doi: 10.1186/s40478-016-0301-z.

4.

Disease-modifying therapies in frontotemporal lobar degeneration.

Bigni B, Premi E, Pilotto A, Padovani A, Borroni B.

Curr Med Chem. 2012;19(7):1008-20. Review.

PMID:
22257060
5.

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

van Swieten JC, Heutink P.

Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2. Review.

PMID:
18771956
6.

Frontotemporal dementia: An updated overview.

Mohandas E, Rajmohan V.

Indian J Psychiatry. 2009 Jan;51 Suppl 1:S65-9.

7.

[Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment].

Rosenmann H, Meiner Z.

Harefuah. 2013 Nov;152(11):661-6, 687. Review. Hebrew.

PMID:
24416825
8.

An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration.

Boxer AL, Lipton AM, Womack K, Merrilees J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D, Miller BL.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7. doi: 10.1097/WAD.0b013e318197852f.

9.

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM; Consortium for Frontotemporal Lobar Degeneration.

Acta Neuropathol. 2007 Jul;114(1):5-22. Epub 2007 Jun 20.

10.

Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Galimberti D, Scarpini E.

Int J Clin Exp Med. 2010 May 15;3(2):129-43.

11.

Clinical and molecular aspects of frontotemporal dementia.

Froelich-Fabre S, Skoglund L, Ostojic J, Kilander L, Lindau M, Glaser A, Basun H, Lannfelt L.

Neurodegener Dis. 2004;1(4-5):218-24. Review.

PMID:
16908993
12.

From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.

Hales CM, Hu WT.

Int Rev Psychiatry. 2013 Apr;25(2):210-20. doi: 10.3109/09540261.2013.776522. Review.

PMID:
23611350
13.

Mouse models of frontotemporal dementia.

Roberson ED.

Ann Neurol. 2012 Dec;72(6):837-49. doi: 10.1002/ana.23722. Review.

14.

[History and classification of frontotemporal lobar degeneration].

Okamoto K.

Brain Nerve. 2009 Nov;61(11):1203-8. Japanese.

PMID:
19938676
15.

[Frontotemporal dementia: a review].

Chauvire V, Even C, Thuile J, Rouillon F, Guelfi JD.

Encephale. 2007 Dec;33(6):933-40. doi: 10.1016/j.encep.2006.12.001. Epub 2007 Sep 6. Review. French.

PMID:
18789785
16.

[Brain functional imaging of frontotemporal lobar degeneration].

Nakano S, Matsuda H.

Brain Nerve. 2009 Nov;61(11):1275-84. Review. Japanese.

PMID:
19938684
17.

Microarray gene and miRNA expression studies: looking for new therapeutic targets for frontotemporal lobar degeneration.

Milanesi E, Pilotto A.

Drug Dev Res. 2014 Sep;75(6):366-71. doi: 10.1002/ddr.21224. Review.

PMID:
25195580
18.

Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.

Boxer AL, Garbutt S, Seeley WW, Jafari A, Heuer HW, Mirsky J, Hellmuth J, Trojanowski JQ, Huang E, DeArmond S, Neuhaus J, Miller BL.

Arch Neurol. 2012 Apr;69(4):509-17. doi: 10.1001/archneurol.2011.1021.

19.

The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.

Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM.

Brain. 2011 Sep;134(Pt 9):2478-92. doi: 10.1093/brain/awr189. Epub 2011 Aug 11.

PMID:
21840888
20.

A new subtype of frontotemporal lobar degeneration with FUS pathology.

Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR.

Brain. 2009 Nov;132(Pt 11):2922-31. doi: 10.1093/brain/awp214. Epub 2009 Aug 11.

Supplemental Content

Support Center